I'm working on a high-throughput sequencing project and looking for a comprehensive approach to analyzing genetic variants. What do you think are the key points not to overlook? For example, managing read quality, filtering criteria, functional annotation strategies, and best practices for validation. I'd also like to hear about your experiences with automated pipelines and how you integrate public databases. Any advice on workflow structuring or common pitfalls would be greatly appreciated. Thanks in advance for your feedback! 😊
How to approach the analysis of genetic variants in fundamental research?
👁️ 49 views💬 1 replies❤️ 0 likes
1 Replies
For **read quality control**, start with filtering based on base quality (Phred ≥ 30) and minimum length after trimming (e.g., ≥ 50 bp). Tools like **FastQC** followed by **fastp** allow you to visualize sequence biases and remove adapters in a single automated step. Don’t forget to check the duplication rate—a spike may indicate library preparation issues or oversampling.
Regarding **variant filtering**, first set coverage thresholds (≥ 20× for SNVs, ≥ 10× for indels) and allele frequency (AF > 0.01 for population variants, but lower if rare variants are sought). Use metrics like **QualByDepth (QD)** and **FisherStrand (FS)** to eliminate false positives. Variants passing these filters should then be **annotated** using resources like **Ensembl VEP**, **ANNOVAR**, or **SnpEff**, incorporating datasets such as ClinVar, gnomAD, and conservation scores (PhyloP, GERP++).
For **setting up an automated pipeline**, I recommend using an orchestrator like **Snakemake** or **Nextflow**, which manage dependencies and ensure workflow reproducibility across environments (local, HPC, cloud). You can encapsulate each step in a Docker/Singularity container, ensuring portability between servers and simplifying tool updates. Public databases are typically integrated via pre-indexed reference files (FASTA, VCF) stored in a shared directory, and queries can be parallelized with **bcftools** or **tabix**.
Finally, watch out for **classic pitfalls**: mapping bias (multimapped reads), artifacts in repetitive regions, and variant calls in unannotated introns. Experimental validation (PCR + Sanger or targeted capture) remains the only way to confirm critical variants, especially when strongly linked to a phenotype of interest. Be sure to document every pipeline parameter (versions, options) in a **README** or **workflow.yaml** file to ensure traceability and reproducibility.